Featured Stories
GeneLab Raises $100M Series C to Expand Global Genetic Testing Services
GeneLab announces successful Series C funding round led by top healthcare investors to accelerate expansion into emerging markets and develop next-generation AI-powered genetic analysis tools.
Breakthrough Study: AI Predicts Cancer Risk with 99.2% Accuracy
Our latest research published in Nature Medicine demonstrates unprecedented accuracy in cancer risk prediction using machine learning algorithms trained on 500,000+ genetic profiles.
Latest Articles
7 articles foundGeneLab Wins Healthcare Innovation Award 2025
Recognized for revolutionary contributions to personalized medicine and genetic testing accessibility at the Global Healthcare Innovation Summit.
New GenePharma Test Launches: Personalized Medication Guidance
Introducing GenePharma, our most comprehensive pharmacogenomic test covering 300+ medications and 150+ genetic markers for optimal drug selection and dosing.
Partnership with Mayo Clinic Advances Precision Medicine Research
Strategic collaboration aims to accelerate development of precision medicine protocols and expand genetic testing applications in clinical settings.
GeneLab Expands to 15 New Countries in Asia-Pacific Region
Major expansion brings cutting‑edge genetic testing services to millions more people across Southeast Asia, India, and Australia.
Rare Disease Gene Discovery Opens New Treatment Pathways
Groundbreaking research identifies 47 previously unknown genetic markers for rare diseases, potentially benefiting 100,000+ patients worldwide.
GeneLab Mobile App Reaches 1 Million Downloads
Our AI‑powered mobile app for genetic health insights crosses major milestone, with users reporting 95% satisfaction rate.
CEO Interview: The Future of Personalized Healthcare
Exclusive interview with GeneLab CEO discussing vision for democratizing genetic testing and making personalized medicine accessible to everyone.